The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2026

Filed:

May. 25, 2021
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Université DE Strasbourg, Stasbourg, FR;

Etat Français Représenté Par LA Direction Centrale Du Service DE Santé Des Armees, Paris, FR;

Inventors:

Rachid Baati, Strasbourg, FR;

José Dias, Brétigny sur Orge, FR;

Florian Nachon, Brétigny sur Orge, FR;

Raymond Franck Razafindrainibe, Schiltigheim, FR;

Mallikarjuna Reddy Nimmakayala, Strasbourg, FR;

Camille Voros, Strasbourg, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 413/06 (2006.01); A61P 25/28 (2006.01); C07D 277/28 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 417/06 (2013.01); A61P 25/28 (2018.01); C07D 277/28 (2013.01); C07D 413/06 (2013.01); C07D 417/12 (2013.01);
Abstract

The present invention relates to a compound of formula (I). It also relates to a pharmaceutical composition comprising at least one compound of formula (I) and at least one pharmaceutically acceptable support. Finally, it relates to the compounds of formula (I) for use in a method of medical treatment, preferably in the treatment of a nervous and/or respiratory failure due to intoxication with at least one organo-phosphorous nerve agent (OPNA); in the treatment of neurological diseases such as Alzheimer's disease; and/or in the treatment of cancer. The compounds act as reactivators of OPNA-inhibited hAChE (human acetylcholinesterase).


Find Patent Forward Citations

Quick Actions:

Baati, Rachid. (2026). Thiazoloxime and oxazoloxime derivatives as reactivators of organophosphorous nerve agent (opna)-inhibited human acetylcholinesterase for the treatment of nervous and/or respiratory failure after intoxication with opna (U.S. Patent No. 12799106). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12799106

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…